Hepatitis News and Research

RSS

Liver transplantation outcomes have significantly improved for patients with hepatitis B

Since the early 1990s, therapeutic options for patients undergoing liver transplantation for hepatitis B have evolved to include HBV immune globulin (HBIG) and lamivudine.

9 Aug 2004

Significant advance in the understanding of the hepatitis C virus (HCV)

Researchers have made a significant advance in the understanding of the hepatitis C virus (HCV) by identifying new genetic factors associated with clearing the virus spontaneously without the necessity for additional treatment.

9 Aug 2004

Correlation between HCV viral load and severity of liver disease

The significance of hepatitis C virus (HCV) serum titers (HCV viral load) has been examined in several clinical situations. There is much evidence that patients with a lower viral load have better response rates to anti-viral therapy compared to those with higher levels.

9 Aug 2004

Self-recovery from Hep C infection linked to genes that suppress action of killer immune cells

In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.

5 Aug 2004

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Metabasis Therapeutics has announced the initiation of a multi-center, multi- national Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate in chronic hepatitis B (HBV) infected patients.

3 Aug 2004

America's childhood immunization rates are at record high levels

The U. S. Department of Health and Human Services has announced that the nation's childhood immunization rates are at record high levels, including significant increases in rates of immunization for chickenpox and pneumococcal pneumonia, the two most recent additions to the childhood immunization schedule.

2 Aug 2004

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Sydney University medical researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS in the latest round of National Health and Medical Research Council program grants.

2 Aug 2004

Drug to fight virus from the herpes family in transplant patients moves forward in trials

A drug once considered for cancer chemotherapy is advancing in clinical trials to test its effectiveness in fighting a virus from the herpes family that threatens transplant patients.

29 Jul 2004

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

Feeling sick can be "all in the head" for people with inflammatory disorders or for those receiving immunotherapy, say Robert Dantzer and Keith Kelley, professors in the department of animal sciences at the University of Illinois at Urbana-Champaign.

29 Jul 2004

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

An international study with nearly 900 patients co-infected with Human Immunodeficiency Virus (HIV) and hepatitis C virus (HCV) has shown that HCV can be treated effectively and safely, without compromising the patient’s HIV therapy.

29 Jul 2004

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

A new study reveals the highest efficacy rates ever reported among patients co-infected with hepatitis C and HIV treated with pegylated interferon and ribavirin.

28 Jul 2004

British Government needs to get its act together to tackle the soaring rates of sexually transmitted infections

The Chairman of the British Medical Association, Mr James Johnson, has called on the Government to get its act together to tackle the soaring rates of sexually transmitted infections (STIs). The Health Protection Agency (HPA) figures for 2003 released today [27 July] show that STI rates are still on the increase in England, Wales and Northern Ireland.

27 Jul 2004

European scientists expect to begin human trials using pharmaceuticals grown in GM plants

The European Union has awarded €12 million to a network of scientists in 11 European countries and South Africa and the aim is to use plants to produce vaccines and treatments against major diseases including AIDS, rabies, diabetes and TB.

23 Jul 2004

Young holidaymaker's traveling overseas face serious health issues from casual sex

A paper published this week in the British Medical Journal says that young holidaymaker's traveling overseas face serious health issues from casual sex, and even goes as far as to suggest that some could be at risk of death.

23 Jul 2004

Computer modeling method for mapping the evolution of the influenza virus

A University of California scientist working at Los Alamos National Laboratory with collaborators from the University of Cambridge (England) and the World Health Organization National Influenza Center at Erasmus Medical Center, (Rotterdam, Netherlands) have developed a computer modeling method for mapping the evolution of the influenza virus.

21 Jul 2004

Illinois bill that allows people with HIV to donate organs to other people who are HIV-positive

The bill was written by state representative Larry McKeon, who has HIV, and signed by Governor Rod R. Blagojevich. In the past, people with HIV were not considered good candidates for transplantation because of a reduced life expectancy. Drug treatments are now more advanced, and people with HIV are living longer.

21 Jul 2004

Hepatitis News and Research

Liver transplantation outcomes have significantly improved for patients with hepatitis B

Significant advance in the understanding of the hepatitis C virus (HCV)

Correlation between HCV viral load and severity of liver disease

Self-recovery from Hep C infection linked to genes that suppress action of killer immune cells

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

America's childhood immunization rates are at record high levels

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Drug to fight virus from the herpes family in transplant patients moves forward in trials

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

British Government needs to get its act together to tackle the soaring rates of sexually transmitted infections

European scientists expect to begin human trials using pharmaceuticals grown in GM plants

Young holidaymaker's traveling overseas face serious health issues from casual sex

Computer modeling method for mapping the evolution of the influenza virus

Illinois bill that allows people with HIV to donate organs to other people who are HIV-positive

Roche files for application with FDA to market hepatitis C medication Pegasys(R) for chronic hepatitis B treatment

Teen birth rate hits record low and prevalence of overweight among children has increased

General childhood intelligence may be an important and informative early determinant of subsequent adult health

More than 20 percent of preschool children lack required immunizations

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News